Details
Stereochemistry | RACEMIC |
Molecular Formula | C16H23NO |
Molecular Weight | 245.3599 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCC(N1CCCC1)C(=O)C2=CC=C(C)C=C2
InChI
InChIKey=SWUVZKWCOBGPTH-UHFFFAOYSA-N
InChI=1S/C16H23NO/c1-3-6-15(17-11-4-5-12-17)16(18)14-9-7-13(2)8-10-14/h7-10,15H,3-6,11-12H2,1-2H3
Pyrovalerone is a psychostimulant. It has a central action. Pyrovalerone inhibits the dopamine transporter and the norepinephrine transporter, and is a weak inhibitor of the serotonin transporter. Pyrovalerone was demonstrated to reduce symptoms of chronic fatigue in humans. It stimulated locomotor activity in mice. Though pyrovalerone is still occasionally prescribed, it is used infrequently due to problems with abuse and dependence. Side effects of pyrovalerone include anxiety, fragmented sleep or insomnia and trembling, shaking or muscle tremors.
CNS Activity
Approval Year
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C47795
Created by
admin on Fri Dec 15 16:15:12 GMT 2023 , Edited by admin on Fri Dec 15 16:15:12 GMT 2023
|
||
|
WIKIPEDIA |
Designer-drugs-Pyrovalerone
Created by
admin on Fri Dec 15 16:15:12 GMT 2023 , Edited by admin on Fri Dec 15 16:15:12 GMT 2023
|
||
|
DEA NO. |
1485
Created by
admin on Fri Dec 15 16:15:12 GMT 2023 , Edited by admin on Fri Dec 15 16:15:12 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C005719
Created by
admin on Fri Dec 15 16:15:12 GMT 2023 , Edited by admin on Fri Dec 15 16:15:12 GMT 2023
|
PRIMARY | |||
|
100000080852
Created by
admin on Fri Dec 15 16:15:12 GMT 2023 , Edited by admin on Fri Dec 15 16:15:12 GMT 2023
|
PRIMARY | |||
|
PYROVALERONE
Created by
admin on Fri Dec 15 16:15:12 GMT 2023 , Edited by admin on Fri Dec 15 16:15:12 GMT 2023
|
PRIMARY | |||
|
3563-49-3
Created by
admin on Fri Dec 15 16:15:12 GMT 2023 , Edited by admin on Fri Dec 15 16:15:12 GMT 2023
|
PRIMARY | |||
|
CHEMBL201960
Created by
admin on Fri Dec 15 16:15:12 GMT 2023 , Edited by admin on Fri Dec 15 16:15:12 GMT 2023
|
PRIMARY | |||
|
m9392
Created by
admin on Fri Dec 15 16:15:12 GMT 2023 , Edited by admin on Fri Dec 15 16:15:12 GMT 2023
|
PRIMARY | Merck Index | ||
|
C83918
Created by
admin on Fri Dec 15 16:15:12 GMT 2023 , Edited by admin on Fri Dec 15 16:15:12 GMT 2023
|
PRIMARY | |||
|
VOU69C02JP
Created by
admin on Fri Dec 15 16:15:12 GMT 2023 , Edited by admin on Fri Dec 15 16:15:12 GMT 2023
|
PRIMARY | |||
|
1737
Created by
admin on Fri Dec 15 16:15:12 GMT 2023 , Edited by admin on Fri Dec 15 16:15:12 GMT 2023
|
PRIMARY | |||
|
DTXSID20863194
Created by
admin on Fri Dec 15 16:15:12 GMT 2023 , Edited by admin on Fri Dec 15 16:15:12 GMT 2023
|
PRIMARY | |||
|
14373
Created by
admin on Fri Dec 15 16:15:12 GMT 2023 , Edited by admin on Fri Dec 15 16:15:12 GMT 2023
|
PRIMARY | |||
|
3511
Created by
admin on Fri Dec 15 16:15:12 GMT 2023 , Edited by admin on Fri Dec 15 16:15:12 GMT 2023
|
PRIMARY | |||
|
SUB10177MIG
Created by
admin on Fri Dec 15 16:15:12 GMT 2023 , Edited by admin on Fri Dec 15 16:15:12 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)